Shahab Falahi

Dr. Shahab Falahi


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 December 2021 in Journal of Medical Virology
Verified
Journal Article
Open access
PDF file
SFShahab Falahi
Shahab Falahi
AKAzra Kenarkoohi
Azra Kenarkoohi
The efficacy of the vaccines varies between individuals and populations. The immunogenicity of the vaccine is influenced by various factors, including host factors. Previous studies have shown that host factors affect the effectiveness of vaccines, which may be true about COVID‐19 vaccines. In this review, we evaluate the possible association of host factors with vaccine efficacy with a special focus on COVID‐19 vaccines.

17 July 2023 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
MFMehdi Fattahi
Mehdi Fattahi
SSSaeid Shahrabi
Saeid Shahrabi
FSFatemeh Saadatpour
Fatemeh Saadatpour
DRDelsuz Rezaee
Delsuz Rezaee
ZBZahra Beyglu
Zahra Beyglu
BLBinh Nguyen Le
Binh Nguyen Le

28 August 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
AHAva Hashempour
Ava Hashempour
NKNastaran Khodadad
Nastaran Khodadad
SAShokufeh Akbarinia
Shokufeh Akbarinia
FGFarzane Ghasabi
Farzane Ghasabi
YGYounes Ghasemi
Younes Ghasemi
SFShahab Falahi
Shahab Falahi
Substantial advances have been made in the development of promising HIV vaccines to eliminate HIV-1 infection. For the first time, one hundred of the most submitted HIV subtypes and CRFs were retrieved from the LANL database, and the consensus sequences of the eleven HIV proteins were obtained to design vaccines for human and mouse hosts. By using various servers and filters, highly qualified B-cell epitopes, as well as HTL and CD8 + epitopes that were common between mouse and human alleles and were also located in the conserved domains of HIV proteins, were considered in the vaccine constructs. With 90% coverage worldwide, the human vaccine model covers a diverse allelic population, making it widely available. Codon optimization and in silico cloning in prokaryotic and eukaryotic vectors guarantee high expression of the vaccine models in human and E. coli hosts. Molecular dynamics confirmed the stable interaction of the vaccine constructs with TLR3, TLR4, and TLR9, leading to a substantial immunogenic response to the designed vaccine. Vaccine models effectively target the humoral and cellular immune systems in humans and mice; however, experimental validation is needed to confirm these findings in silico.

1 December 2020 in Heliyon
Verified
Journal Article
Open access
AAAmir Abdoli
Amir Abdoli
ATAli Taghipour
Ali Taghipour
MPMajid Pirestani
Majid Pirestani
MJMirza Ali Mofazzal Jahromi
Mirza Ali Mofazzal Jahromi
ARAbazar Roustazadeh
Abazar Roustazadeh
MKMahdi Karimi
Mahdi Karimi
Neuropsychiatric disorders (NPDs) have multiple etiological factors, mainly genetic background, environmental conditions and immunological factors. The host immune responses play a pivotal role in various physiological and pathophysiological process. In NPDs, inflammatory immune responses have shown to be involved in diseases severity and treatment outcome. Inflammatory cytokines and chemokines are involved in various neurobiological pathways, such as GABAergic signaling and neurotransmitter synthesis. Infectious agents are among the major amplifier of inflammatory reactions, hence, have an indirect role in the pathogenesis of NPDs. As such, some infections directly affect the central nervous system (CNS) and alter the genes that involved in neurobiological pathways and NPDs. Interestingly, the most of infectious agents that involved in NPDs (e.g., Toxoplasma gondii, cytomegalovirus and herpes simplex virus) is latent (asymptomatic) and co-or-multiple infection of them are common. Nonetheless, the role of co-or-multiple infection in the pathogenesis of NPDs has not deeply investigated. Evidences indicate that co-or-multiple infection synergically augment the level of inflammatory reactions and have more severe outcomes than single infection. Hence, it is plausible that co-or-multiple infections can increase the risk and/or pathogenesis of NPDs. Further understanding about the role of co-or-multiple infections can offer new insights about the etiology, treatment and prevention of NPDs. Likewise, therapy based on anti-infective and anti-inflammatory agents could be a promising therapeutic option as an adjuvant for treatment of NPDs.

27 April 2023 in New Microbes and New Infections
Verified
Journal Article
Open access
SFShahab Falahi
Shahab Falahi
AAAmir Abdoli
Amir Abdoli
AKAzra Kenarkoohi
Azra Kenarkoohi
Immunoneuropsychiatry is an emerging field about the interaction between the immune and nervous systems. Infection and infection-related inflammation (in addition to genetics and environmental factors) can act as the etiopathogenesis of neuropsychiatric disorders (NPDs). Exposure to COVID-19 in utero may be a risk factor for developing NPDs in offspring in the future. Maternal immune activation (MIA) and subsequent inflammation can affect fetal brain development. Inflammatory mediators, cytokines, and autoantibodies can pass through the placenta and the compromised blood-brain barrier after MIA, leading to neuroinflammation. Neuroinflammation also affects multiple neurobiological pathways; for example, it decreases the production of the neurotransmitter serotonin.

1 July 2012 in Hepatitis Monthly
Verified
Journal Article
Open access
PDF file
AKAzra Kenar Koohi
Azra Kenar Koohi
MRMehrdad Ravanshad
Mehrdad Ravanshad
MRManouchehr Rasouli
Manouchehr Rasouli
SFShahab Falahi
Shahab Falahi
ABAshraf Baghban
Ashraf Baghban
Phylogenetic Analysis of Torque Teno Virus in Hepatitis C Virus Infected Patients in Shiraz - Hepatitis Monthly - 2012 - Kowsar